Apr 15, 2019 Cerecor Announces Positive Interim Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (nOH)
Feb 19, 2019 Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency
Jan 28, 2019 Cerecor Announces U.S. Headquarters Move Into Pharmaceutical Corridor of Rockville, Maryland
Jan 22, 2019 FDA Accepts IND Application for Cerecor’s Investigational Drug CERC-801 for the treatment of PGM1 Deficiency
